Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-04-27 | 2023-08-18 | 190734 |
TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190731 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190728 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190725 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190722 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190719 |
TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-09 | 190716 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-06-27 | 190713 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-04-27 | 2023-10-26 | 190710 |
REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-30 | 190704 |
TEVA-CODEINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190701 |
FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2023-04-27 | 2023-06-21 | 190698 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190695 |
TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190692 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-04-27 | 2023-11-21 | 190680 |
TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-04-27 | 2024-01-08 | 190677 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |